Primidone Dosage
This dosage information may not include all the information needed to use Primidone safely and effectively. See additional information for Primidone.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Seizures
Days 1 to 3: 100 to 125 mg orally at bedtime
Days 4 to 6: 100 to 125 mg orally twice a day
Days 7 to 9: 100 to 125 mg orally three times a day
Day 10 onward: 250 mg orally three to four times a day, increasing up to five or six times a day if necessary, not to exceed 500 mg four times a day (2 g/day).
Usual Pediatric Dose for Seizures
Neonates:
12 to 20 mg/kg/day in 2 to 4 divided doses, beginning with lower dosage and titrating upward
Children:
Less than 8 years:
Initial dose: 50 to 125 mg/day given at bedtime and increased by increments of 50 to 125 mg/day every 3 to 7 days
Maintenance dose: 10 to 25 mg/kg/day in 3 to 4 divided doses
Greater than or equal to 8 years:
Initial dose: 125 to 250 mg/day at bedtime and increased by increments of 125 to 250 mg/day every 3 to 7 days
Maintenance dose: 750 to 1500 mg/day in 3 to 4 divided doses
Maximum dose: 2 g/day
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dose Adjustments
For patients already receiving other anticonvulsants:
Start with 100 to 125 mg at bedtime, gradually increasing to a maintenance level as the other drug is decreased. The regimen should be continued until a satisfactory dosage level is achieved for the combination or until the other medication is completely withdrawn. The transition to primidone monotherapy should not be completed in less than two weeks.
Precautions
Primidone is contraindicated in patients with porphyria and patients who are hypersensitive to phenobarbital.
Abrupt withdrawal of antiepileptic medications may lead to status epilepticus.
Dialysis
Data not available
Other Comments
The manufacturer recommends a complete blood count (CBC) and sequential multiple analysis 12 (SMA-12) every 6 months if a patient is to remain on primidone therapy.
The therapeutic efficacy of a dosage regimen may take several weeks before it can be assessed.


